A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.

The hateful eight? The US Food and Drug Administration announced a plan Tuesday to phase out eight petroleum-based synthetic ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

The FDA's move stops short of the outright ban that had been floated for in Kennedy's "Make America Healthy Again" platform ...

The federal health department has said it will move to phase out eight artificial dyes, citing health concerns.

Robert F. Kennedy Jr. ordered food companies to remove petroleum-based food dyes by 2027. Here's the science linking dyes to ...

The leadership shown by HHS in addressing this problem with clear guidelines and expectations provides much-needed clarity to ...

The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...

U.S. health agencies announced that the food industry will begin "phasing out" eight artificial food dyes in the coming years ...